• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经精神症状与轻度认知障碍患者向阿尔茨海默病进展的风险。

Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.

机构信息

Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France.

Institut de Recherches Internationales Servier, Suresnes, France.

出版信息

J Alzheimers Dis. 2019;70(1):25-34. doi: 10.3233/JAD-190025.

DOI:10.3233/JAD-190025
PMID:31127783
Abstract

BACKGROUND

Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia.

OBJECTIVE

To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI.

METHODS

96 MCI participants were followed for 4 years. Progression to probable AD was defined by the change of CDR total score from 0.5 to ≥1, reviewed by an expert consensus panel. NPS were determined using the Neuropsychiatric Inventory (NPI) 12-items. This study analyzed prognostic value of each NPI item and 5 sub-syndromes of NPS (apathy, psychosis, affective, hyperactivity, and vegetative) for prediction of progression to probable AD. A Cox proportional hazard model was used; hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with time dependent variable to compare the incidence of progression considering presence/absence of any NPS or sub-syndromes throughout the study.

RESULTS

The presence of symptoms "agitation/aggression", "delusions", and "aberrant motor behavior" significantly increased the risk of probable AD (HR = 3.9; 95% CI = 1.9-8.2; HR = 13.9; 95% CI = 4.1-48.9; HR = 4.3; 95% CI = 1.7-10.3, respectively). The presence of sub-syndromes "psychosis" and "hyperactivity" were also predictors of progression (HR = 14.0; 95% CI = 4.4-44.5; HR = 2.0; 95% CI = 1.1-3.7, respectively). These results did not change after adjusting by potential confounders.

CONCLUSION

Presence of delusions, agitation/aggression, and aberrant motor behavior is predictor of progression to probable AD.

摘要

背景

神经精神症状(NPS)在轻度认知障碍(MCI)中较为常见,但我们对其在向痴呆进展中的作用知之甚少。

目的

研究 MCI 患者的 NPS 与向可能的阿尔茨海默病痴呆(AD)进展的风险。

方法

96 名 MCI 参与者随访 4 年。进展为可能的 AD 通过 CDR 总分从 0.5 变为≥1 来定义,由专家共识小组进行审查。使用神经精神病学问卷(NPI)的 12 项来确定 NPS。本研究分析了每个 NPI 项目和 NPS 的 5 个亚综合征(冷漠、精神病、情感、多动和植物神经)对预测向可能的 AD 进展的预后价值。使用 Cox 比例风险模型;使用时间相关变量估计风险比(HR)和 95%置信区间(CI),以考虑在整个研究期间是否存在任何 NPS 或亚综合征来比较进展的发生率。

结果

症状“激越/攻击”、“妄想”和“异常运动行为”的存在显著增加了可能 AD 的风险(HR=3.9;95%CI=1.9-8.2;HR=13.9;95%CI=4.1-48.9;HR=4.3;95%CI=1.7-10.3)。亚综合征“精神病”和“多动”的存在也是进展的预测因素(HR=14.0;95%CI=4.4-44.5;HR=2.0;95%CI=1.1-3.7)。这些结果在调整潜在混杂因素后没有改变。

结论

妄想、激越/攻击和异常运动行为的存在是向可能的 AD 进展的预测因素。

相似文献

1
Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.神经精神症状与轻度认知障碍患者向阿尔茨海默病进展的风险。
J Alzheimers Dis. 2019;70(1):25-34. doi: 10.3233/JAD-190025.
2
Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.ADNI 多中心观察队列研究:脑淀粉样变与 AD 神经精神症状的发生率和频率的关系。
BMJ Open. 2019 Dec 18;9(12):e031947. doi: 10.1136/bmjopen-2019-031947.
3
Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.阿尔茨海默病轻度认知障碍及不同痴呆阶段的神经精神症状的频率和亚组。
Int Psychogeriatr. 2018 Jan;30(1):103-113. doi: 10.1017/S1041610217001879. Epub 2017 Sep 20.
4
Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.轻度认知障碍中的抑郁与阿尔茨海默病的进展相关:一项纵向研究。
J Alzheimers Dis. 2014;42(4):1239-50. doi: 10.3233/JAD-140405.
5
The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.阿尔茨海默病神经精神症状在五年随访期间的进展:库奥皮奥ALSOVA研究
J Alzheimers Dis. 2018;61(4):1367-1376. doi: 10.3233/JAD-170697.
6
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.行为亚综合征对阿尔茨海默病认知衰退的影响:来自 ICTUS 研究的数据。
J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1007/s00415-013-6893-3. Epub 2013 Mar 17.
7
Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly.社区居住的亚洲老年人中神经精神症状及亚综合征与认知障碍的关联。
Int Psychogeriatr. 2015 Nov;27(11):1839-47. doi: 10.1017/S1041610215000976. Epub 2015 Jul 23.
8
The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.冷漠评估量表:认知正常老年人与轻度认知障碍患者的自评、知情者评和临床医生评比较
J Alzheimers Dis. 2015;47(2):421-32. doi: 10.3233/JAD-150146.
9
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.轻度认知障碍和阿尔茨海默病痴呆患者的神经精神症状和脑形态。
Int Psychogeriatr. 2021 Nov;33(11):1217-1228. doi: 10.1017/S1041610221000934. Epub 2021 Aug 17.
10
Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.神经精神症状对轻度认知障碍和阿尔茨海默病患者的影响不同:一项回顾性观察研究。
Neurol Sci. 2019 Jul;40(7):1377-1382. doi: 10.1007/s10072-019-03840-4. Epub 2019 Mar 22.

引用本文的文献

1
Insulin-like Growth Factor 1 Impact on Alzheimer's Disease: Role in Inflammation, Stress, and Cognition.胰岛素样生长因子1对阿尔茨海默病的影响:在炎症、应激和认知中的作用
Curr Issues Mol Biol. 2025 Mar 27;47(4):233. doi: 10.3390/cimb47040233.
2
Understanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer's Disease.了解神经精神症状在阿尔茨海默病功能衰退中的作用。
J Neuropsychiatry Clin Neurosci. 2025 Jun 26:appineuropsych20250015. doi: 10.1176/appi.neuropsych.20250015.
3
Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment.
轻度认知障碍中的神经精神症状和特定认知领域
Dement Neuropsychol. 2025 Jan 13;18:e20240187. doi: 10.1590/1980-5764-DN-2024-0187. eCollection 2024.
4
CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome.CAPS:一种用于临床阿尔茨海默综合征中β-淀粉样蛋白阳性预测的简单临床工具。
Front Neurol. 2024 Aug 14;15:1422681. doi: 10.3389/fneur.2024.1422681. eCollection 2024.
5
Housing status is protective of neuropsychiatric symptoms among dementia-free multi-ethnic Asian elderly.住房状况可保护无痴呆症的多族裔亚裔老年人的神经精神症状。
BMC Geriatr. 2024 Aug 23;24(1):698. doi: 10.1186/s12877-024-05203-x.
6
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression.血浆神经丝轻链、胶质纤维酸性蛋白和磷酸化 tau181 作为神经精神症状和相关临床疾病进展的生物标志物。
Alzheimers Res Ther. 2024 Jul 25;16(1):165. doi: 10.1186/s13195-024-01526-4.
7
Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline.阿尔茨海默病的神经精神症状特征及其与功能衰退的关系。
Am J Geriatr Psychiatry. 2024 Dec;32(12):1402-1416. doi: 10.1016/j.jagp.2024.06.005. Epub 2024 Jun 29.
8
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting.生长抑素:将认知与阿尔茨海默病联系起来,以作为治疗靶点。
Pharmacol Rev. 2024 Oct 16;76(6):1291-1325. doi: 10.1124/pharmrev.124.001117.
9
Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults.轻度行为障碍领域与痴呆前老年人的 pTAU 和代谢生物标志物具有纵向相关性。
Alzheimers Dement. 2024 Jul;20(7):4692-4701. doi: 10.1002/alz.13902. Epub 2024 Jun 14.
10
Comprehensive analysis of genetic risk loci uncovers novel candidate genes and pathways in the comorbidity between depression and Alzheimer's disease.全面分析遗传风险位点揭示了抑郁和阿尔茨海默病共病的新候选基因和途径。
Transl Psychiatry. 2024 Jun 11;14(1):253. doi: 10.1038/s41398-024-02968-y.